ArticleThe Journal of heredity2026
Inducing radiation resilience in frozen animal cells via mRNA coding for tardigrade damage-suppressor protein in support of space travel and Lunar storage.
Article in The Journal of heredity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Earth's biodiversity is at risk. To help safeguard this biodiversity, a Lunar Biorepository at the Moon's south pole has been proposed to hold cryopreserved samples of fibroblast cells from animal species that support fundamental ecosystems on Earth. These samples could be used for revitalization of ecosystems on Earth, genetic rescue, space travel, or possibly terraformation. Initially, samples will be primarily animal cells, but the biorepository would be designed to ultimately include all species on Earth. This biorepository will take decades to build and will potentially span millennia. To make this project a reality, certain prior steps must be taken, such as defining species selection and collection and sample management on Earth before launching in the biorepository. Many of the steps leading to the creation of this biorepository are known, with long-term radiation exposure and risk to the cells being one of the greatest challenges to overcome. It is essential to understand the radiation sensitivity of cells and design strategies to avoid genetic modification to further protect cells from radiation during space travel and long-term storage. After considering various options, this review specifically focuses on exposing fibroblast cells to nanoparticles delivering modified mRNA tardigrade damage-suppressor protein. This protein minimizes DNA damage due to radiation without obvious harmful effects to the tissue and cells. This also could serve as a testbed to study countermeasures against the radiation effects during long-duration, crewed space flights.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.